Rīga Stradiņš University (RSU) will host the BFCS 2026 international conference on 19–20 March 2026 in Riga, Latvia, in collaboration with the Baltic Flow Cytometry Society. The two-day event will ...
Five presentations will showcase nizubaglustat's therapeutic potential in Lysosomal Storage Disorders. Nizubaglustat is currently being tested in two global Phase 3 studies for Niemann-Pick ...
Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that its lead asset, nizubaglustat, will ...
One researcher turned her scientific findings into character dialogue to simplify complex concepts. After seeing how ...
PALI-2108 Abstracts Highlight Gut-Targeted PDE4B Inhibition and Translational Phase 1a Findings in Ulcerative ColitisCarlsbad, CA, ...
AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback